Gracell Biotechnologies
(GRCL)
Financial statements
|
|
Dec 2021 |
Dec 2020 |
| Total Revenue |
|
| |
| Cost of Revenue |
|
| |
| Gross Profit |
|
| |
| Gross Profit Margin (%) |
|
| |
| R&D Expense |
|
| |
| SG&A Expense |
|
| |
| Total Operating Expenses |
|
| |
| Operating Income or Loss |
|
| |
| Operating Margin (%) |
|
| |
| Interest Expense |
|
| |
| Total Other Income/Expenses |
|
| |
| Income Before Tax |
|
| |
| Income Tax Expense |
|
| |
| Income from Continuing Ops. |
|
| |
| Net Income |
|
| |
| Net Profit Margin (%) |
|
| |
| Net Income Available to Common Shareholders |
|
| |
| Basic EPS |
|
| |
| Diluted EPS |
|
| |
| Basic Average Shares |
|
| |
| Diluted Average Shares |
|
| |
|
|
Dec 2021 |
Dec 2020 |
| Total Revenue |
|
| |
| Cost of Revenue |
|
| |
| Gross Profit |
|
| |
| Gross Profit Margin (%) |
|
| |
| R&D Expense |
|
| |
| SG&A Expense |
|
| |
| Total Operating Expenses |
|
| |
| Operating Income or Loss |
|
| |
| Operating Margin (%) |
|
| |
| Interest Expense |
|
| |
| Total Other Income/Expenses |
|
| |
| Income Before Tax |
|
| |
| Income Tax Expense |
|
| |
| Income from Continuing Ops. |
|
| |
| Net Income |
|
| |
| Net Profit Margin (%) |
|
| |
| Net Income Available to Common Shareholders |
|
| |
| Basic EPS |
|
| |
| Diluted EPS |
|
| |
| Basic Average Shares |
|
| |
| Diluted Average Shares |
|
| |
|
|
Dec 2021 |
Dec 2020 |
| Current Assets |
|
| |
| Cash & Cash Equivalents |
|
| |
| Marketable Securities |
|
| |
| Receivables |
|
| |
| Inventories |
|
| |
| Other Current Assets |
|
| |
| Total Current Assets |
|
| |
| Non-Current Assets |
|
| |
| Marketable Securities |
|
| |
| PPE Net |
|
| |
| Intangibles inc. Goodwill |
|
| |
| Other Non-Current Assets |
|
| |
| Total Non-Current Assets |
|
| |
| Total Assets |
|
| |
| Current Liabilities |
|
| |
| Accounts Payable |
|
| |
| Deferred Revenues |
|
| |
| Debt, Current |
|
| |
| Accrued Liabilities |
|
| |
| Other Current Liabilities |
|
| |
| Total Current Liabilities |
|
| |
| Non-Current Liabilities |
|
| |
| Deferred Revenues |
|
| |
| Debt, Non-Current |
|
| |
| Other Non-Current Liabilities |
|
| |
| Total Non-Current Liabilities |
|
| |
| Total Liabilities |
|
| |
| Shareholders' Equity |
|
| |
| Common Stock |
|
| |
| Additional Paid-In Capital |
|
| |
| Retained Earnings |
|
| |
| Other Shareholders' Equity |
|
| |
| Total Shareholders' Equity |
|
| |
| Total Liabilities & Shareholders' Equity |
|
| |
|
|
Dec 2021 |
Dec 2020 |
| Current Assets |
|
| |
| Cash & Cash Equivalents |
|
| |
| Marketable Securities |
|
| |
| Receivables |
|
| |
| Inventories |
|
| |
| Other Current Assets |
|
| |
| Total Current Assets |
|
| |
| Non-Current Assets |
|
| |
| Marketable Securities |
|
| |
| PPE Net |
|
| |
| Intangibles inc. Goodwill |
|
| |
| Other Non-Current Assets |
|
| |
| Total Non-Current Assets |
|
| |
| Total Assets |
|
| |
| Current Liabilities |
|
| |
| Accounts Payable |
|
| |
| Deferred Revenues |
|
| |
| Debt, Current |
|
| |
| Accrued Liabilities |
|
| |
| Other Current Liabilities |
|
| |
| Total Current Liabilities |
|
| |
| Non-Current Liabilities |
|
| |
| Deferred Revenues |
|
| |
| Debt, Non-Current |
|
| |
| Other Non-Current Liabilities |
|
| |
| Total Non-Current Liabilities |
|
| |
| Total Liabilities |
|
| |
| Shareholders' Equity |
|
| |
| Common Stock |
|
| |
| Additional Paid-In Capital |
|
| |
| Retained Earnings |
|
| |
| Other Shareholders' Equity |
|
| |
| Total Shareholders' Equity |
|
| |
| Total Liabilities & Shareholders' Equity |
|
| |
|
|
Dec 2021 |
Dec 2020 |
| Cash Flows from Operating Activities |
|
| |
| Net Income |
|
| |
| Depreciation & Amortization |
|
| |
| Deferred Income Taxes |
|
| |
| Stock Based Compensation |
|
| |
| Accounts Receivable |
|
| |
| Inventory |
|
| |
| Accounts Payable |
|
| |
| Deferred Revenue |
|
| |
| Other Non-Cash |
|
| |
| Operating Cash Flow |
|
| |
| Cash Flows from Investing Activities |
|
| |
| PPE Investments |
|
| |
| Net Acquisitions |
|
| |
| Purchase of Investments |
|
| |
| Sale of Investments |
|
| |
| Other Investing Activity |
|
| |
| Investing Cash Flow |
|
| |
| Cash Flows from Financing Activities |
|
| |
| Debt Issued |
|
| |
| Proceeds from Debt Repayment |
|
| |
| Debt Repayment |
|
| |
| Proceeds from Sale of Equity |
|
| |
| Equity Repurchased |
|
| |
| Dividend Paid |
|
| |
| Other Financing Activity |
|
| |
| Financing Cash Flow |
|
| |
| Cash Position |
|
| |
| Beginning Cash Position |
|
| |
| End Cash Position |
|
| |
| Change in Cash |
|
| |
| Free Cash Flow |
|
| |
| Operating Cash Flow |
|
| |
| Capital Expenditure |
|
| |
| Free Cash Flow |
|
| |
|
|
Dec 2021 |
Dec 2020 |
| Cash Flows from Operating Activities |
|
| |
| Net Income |
|
| |
| Depreciation & Amortization |
|
| |
| Deferred Income Taxes |
|
| |
| Stock Based Compensation |
|
| |
| Accounts Receivable |
|
| |
| Inventory |
|
| |
| Accounts Payable |
|
| |
| Deferred Revenue |
|
| |
| Other Non-Cash |
|
| |
| Operating Cash Flow |
|
| |
| Cash Flows from Investing Activities |
|
| |
| PPE Investments |
|
| |
| Net Acquisitions |
|
| |
| Purchase of Investments |
|
| |
| Sale of Investments |
|
| |
| Other Investing Activity |
|
| |
| Investing Cash Flow |
|
| |
| Cash Flows from Financing Activities |
|
| |
| Debt Issued |
|
| |
| Proceeds from Debt Repayment |
|
| |
| Debt Repayment |
|
| |
| Proceeds from Sale of Equity |
|
| |
| Equity Repurchased |
|
| |
| Dividend Paid |
|
| |
| Other Financing Activity |
|
| |
| Financing Cash Flow |
|
| |
| Cash Position |
|
| |
| Beginning Cash Position |
|
| |
| End Cash Position |
|
| |
| Change in Cash |
|
| |
| Free Cash Flow |
|
| |
| Operating Cash Flow |
|
| |
| Capital Expenditure |
|
| |
| Free Cash Flow |
|
| |
